[In vitro activity of a new cephalosporin--cefoperazone--against Enterobacteriaceae and Pseudomonas aeruginosa].
431 recent clinical isolates from the families Enterobacteriaceae and Pseudomonadaceae drawn from the western part of Switzerland have been tested for Cefoperazone sensitivity. With 6 exceptions, all strains were susceptible or highly sensitive to the antibiotic. Striking was the excellent activity of cefoperazone against Pseudomonas aeruginosa, Serratia marcescens and indol-positive Proteus species, in contrast that of most of the already established cephalosporins.
D002438:Cefoperazone; D002511:Cephalosporins / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D006801:Humans; D008826:Microbial Sensitivity Tests; D011552:Pseudomonas Infections / Q000188:drug therapy*
D002511:Cephalosporins; D002438:Cefoperazone
In vitro-Aktivität eines neuen Cephalosporins--Cefoperazon--gegen Enterobacteriaceae und Pseudomonas aeruginosa.